Tumor-associated macrophages: Shifting bad prognosis to improved efficacy in cancer therapies?
International Journal of Immunotherapy and Cancer Research(2021)
Abstract
A few tumours are exceptionally stubborn to oral chemotherapy. The endurance of tumours in a few cases is helped by checkpoint immunomodulation to keep up the unevenness between resistant reconnaissance and disease cell division.
MoreTranslated text
Key words
macrophages,cancer therapies,bad prognosis,tumor-associated
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined